Drug Delivery Business

BD to invest $110M to support prefilled syringe production, pharma supply chain

BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, ...
The Hill

US investing $42M to help company ramp up syringe, needle production ahead of vaccination push

The U.S. government is investing $42 million to help Becton, Dickinson and Company, known as BD, ramp up its production of syringes and needles ahead of the future coronavirus vaccination push. The ...
MD&M East

BD Increases US Syringe Production After FDA Warnings on China-Made Syringes

Becton, Dickinson and Company (BD) has announced its intention to increase US production of syringes after FDA recently reported that its ongoing investigation into quality issues with plastic ...
Business Insider

Disposable Hypodermic Syringes Market to Witness a CAGR of 6.2% During 2019-2027 - Growth in the Manufacturing of Single-Use Syringes With Enhanced Patient Safety Will Increase ...

DUBLIN, Feb. 12, 2020 /PRNewswire/ -- The "Global Disposable Hypodermic Syringes Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ...
Nasdaq

Sharps Technology (STSS) To Enter The Copolymer Prefillable Syringe Market With Strength And Ahead of Plan Through Pending Manufacturing Facility Acquisition and $400M Nephron Deal

Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...
FiercePharma

As COVID-19 demand surges, BD blueprints $1.2B expansion to jack up prefilled syringe output by 50%

Becton Dickinson masterminded the prefillable syringe, and decades later, it's a technology key to the global COVID-19 vaccine rollout. And with pandemic demand surging, BD is planning to shell out $1 ...